Clinical Research
Along with normal clinical service, wide range of clinical trials also provided in our center
We are actively recruiting patient to participate in the following clinical trials
Please send referral letter to medicaloncology@hku.hk if interested
Genitourinary
Protocol Number
Protocol Title
Experimental agent
Principle Investigator
BO42843
A Phase III, Double-Blind, multicenter, randomized study of Atezolizumab ( Anti-PD-L1 antibody) versus Placebo as adjuvant therapy in patient with high-risk muscle-invasive Bladder cancer who are ctDNA positive following Cystectomy
Atezolizumab
vs
Placebo
A Phase 3, Open Label, Randomised, 3-Arm, Multi-Centre Study of Savolitinib plus Durvalumab versus Sunitinib and Durvalumab Monotheraphy in Participants with MET-Driven, Unresectable and Locally Advanced or Metastatic Papillary Renal Cell Carcinoma (PRCC) (SAMETA)
durvalumab and savolitinib
vs
durvalumab
vs
sunitinib